1. Home
  2. TARS vs FHB Comparison

TARS vs FHB Comparison

Compare TARS & FHB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TARS
  • FHB
  • Stock Information
  • Founded
  • TARS 2016
  • FHB 1858
  • Country
  • TARS United States
  • FHB United States
  • Employees
  • TARS N/A
  • FHB N/A
  • Industry
  • TARS Medicinal Chemicals and Botanical Products
  • FHB Major Banks
  • Sector
  • TARS Health Care
  • FHB Finance
  • Exchange
  • TARS Nasdaq
  • FHB Nasdaq
  • Market Cap
  • TARS 2.8B
  • FHB 3.0B
  • IPO Year
  • TARS 2020
  • FHB 2016
  • Fundamental
  • Price
  • TARS $77.39
  • FHB $24.12
  • Analyst Decision
  • TARS Strong Buy
  • FHB Sell
  • Analyst Count
  • TARS 7
  • FHB 9
  • Target Price
  • TARS $69.86
  • FHB $28.00
  • AVG Volume (30 Days)
  • TARS 461.9K
  • FHB 1.3M
  • Earning Date
  • TARS 11-04-2025
  • FHB 10-24-2025
  • Dividend Yield
  • TARS N/A
  • FHB 4.35%
  • EPS Growth
  • TARS N/A
  • FHB 17.02
  • EPS
  • TARS N/A
  • FHB 2.05
  • Revenue
  • TARS $366,100,000.00
  • FHB $824,314,000.00
  • Revenue This Year
  • TARS $139.46
  • FHB $12.21
  • Revenue Next Year
  • TARS $49.91
  • FHB $2.25
  • P/E Ratio
  • TARS N/A
  • FHB $11.67
  • Revenue Growth
  • TARS 182.44
  • FHB 1.80
  • 52 Week Low
  • TARS $38.51
  • FHB $20.32
  • 52 Week High
  • TARS $78.76
  • FHB $28.80
  • Technical
  • Relative Strength Index (RSI)
  • TARS 66.65
  • FHB 47.11
  • Support Level
  • TARS $70.84
  • FHB $23.32
  • Resistance Level
  • TARS $78.76
  • FHB $25.22
  • Average True Range (ATR)
  • TARS 3.29
  • FHB 0.51
  • MACD
  • TARS 0.35
  • FHB -0.07
  • Stochastic Oscillator
  • TARS 88.54
  • FHB 43.04

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.

About FHB First Hawaiian Inc.

First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.

Share on Social Networks: